PlexusDx breaks down the science behind storage rules so you can confidently manage your injectable GLP-1 therapy
L-carnitine requires more form selection
SUMMIT refers to tirzepatide studies, not retatrutide
Carroll clarified that the bill would impact the student only if the student were deemed high-acuity
We feared this from the beginning, when we urged cavalier owners to not particpate in the EPIC Trial in our Blog entry, "Beware the pimobendan/Vetmedin 'EPIC clinical trial': There is no upside." Hopefully, between now and when the actual (presumably peer-reviewed) article on the EPIC Trial is published, responsible professionals will re-take control of this process back from the manufacturer and not suggest that death before reaching congestive heart failure is an acceptable end result of giving their dogs pimobendan
A study from the Employee Benefit Research Institute (EBRI), supported by the Blue Cross Blue Shield Association and other partners, estimates that GLP-1 coverage would be a major premium driver for employer-provided coverage